Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Locations section now lists Michigan and Ohio as study sites and the page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and the previous Michigan/Ohio Locations entries were removed.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPublication notes now state that PubMed auto-fill may not all be about the study. The revision version has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding lapse notice and its operating-status reference from the page; no study data, eligibility criteria, or trial details were changed.SummaryDifference0.4%

- Check62 days agoChange DetectedThe two screenshots show only minor UI/layout adjustments; core study data (eligibility criteria, primary outcomes, and enrollment) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference6%

- Check98 days agoChange Detected- The page transitions from an older “No Results Posted” state to a new “Results Submitted” state. - Version tag advances from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.